Teon Therapeutics
San Francisco, United States· Est. 2019
Teon Therapeutics focuses on developing small molecule therapies targeting cancer metabolism and immune-oncology pathways.
Private Company
Total funding raised: $107M
About
Teon Therapeutics focuses on developing small molecule therapies targeting cancer metabolism and immune-oncology pathways.
Small Molecules
Funding History
2Total raised:$107M
Series B$60MDec 15, 2022
Series A$47MJun 15, 2021